mRNA Vaccine History - Search News

FDA to review Moderna's mRNA flu vaccine

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise

The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

Opinion

· 3d

Editorial: Letting disease win — FDA’s dangerous refusal of Moderna’s new mRNA flu vaccine

Opinion

CIDRAP · 1d

CIDRAP Op-Ed: The FDA refused to review a flu vaccine, contrary to evidence. Now the agency reversed itself

· 2d

FDA reverses course on Moderna's flu vaccine

The FDA says it will now review a new m-r-n-a flu vaccine from Moderna.

· 2d

Moderna got a win from the FDA, but political headwinds remain a concern for vaccine makers

· 2d

A Welcome FDA Walkback on a Flu Vaccine

· 2d

Moderna says the FDA will consider its new flu shot after resolving a public dispute

The dispute centered over a 40,000-person clinical trial that concluded Moderna’s new vaccine was more effective in adults aged 50 and older than one of the standard flu shots used today.

WGBH · 1d

State's top health official: FDA's reversal on Moderna's flu vaccine could ‘chill the market’

· 1d

Moderna Wins Regulatory Reversal as U.S. FDA Agrees to Evaluate New Shot

2don MSN

Wednesday's daily dose: A new mRNA flu vaccine, robotic surgery milestone and lung cancer screening

From a potential new flu vaccine to a groundbreaking surgical first and critical health reminders, here's today's essential health news.

The Daily Pennsylvanian

Perelman School of Medicine develops mRNA vaccine to prevent life-threatening allergic reactions

Researchers from the Perelman School of Medicine have developed an mRNA vaccine with the potential to prevent life-threatening allergic reactions. The new vaccine, described in an article published in The Journal of Clinical Investigation, prevented ...

Fierce Pharma

With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment

Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior administration and this administration.”

San Diego Union-Tribune

Opinion: mRNA medicines are the future of modern health — not a threat

Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, a fierce debate has taken place around the future of mRNA-based vaccines and therapeutics. As San Diego-based innovators of ...

World Socialist Web Site

Kennedy’s attacks on mRNA vaccines and science threaten global public health

Robert F. Kennedy Jr., speaks after being sworn in as health and human services secretary in the Oval Office at the White House, Thursday, Feb. 13, 2025. [AP Photo/Alex Brandon] In the past few weeks, Robert F. Kennedy Jr. has dramatically reshaped America ...

Opinion

2dOpinion

Vaccine slump risks a downward financial spiral

Pharma groups like $113 bln Sanofi and Pfizer have spent years investing in immunisations. But scepticism from the US government, and citizens, means shrinking sales. The danger is that it reduces corporate investment,

9don MSN

First mRNA vaccine to be produced in UK approved

First mRNA vaccine to be produced in UK approved by regulators - The Moderna Innovation and Technology Centre will make millions of cutting-edge mRNA vaccines